Annual Cash & Cash Equivalents
$27.66 M
+$1.82 M+7.04%
31 December 2023
Summary:
Chimerix annual cash & cash equivalents is currently $27.66 million, with the most recent change of +$1.82 million (+7.04%) on 31 December 2023. During the last 3 years, it has fallen by -$19.33 million (-41.13%). CMRX annual cash & cash equivalents is now -78.47% below its all-time high of $128.46 million, reached on 31 December 2014.CMRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$23.64 M
+$7.99 M+51.01%
30 September 2024
Summary:
Chimerix quarterly cash and cash equivalents is currently $23.64 million, with the most recent change of +$7.99 million (+51.01%) on 30 September 2024. Over the past year, it has increased by +$9.53 million (+67.48%). CMRX quarterly cash and cash equivalents is now -91.38% below its all-time high of $274.26 million, reached on 30 September 2022.CMRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMRX Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.0% | +67.5% |
3 y3 years | -41.1% | -9.7% |
5 y5 years | -65.9% | +22.2% |
CMRX Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -41.1% | +79.7% | -91.4% | +67.5% |
5 y | 5 years | -65.9% | +79.7% | -91.4% | +67.5% |
alltime | all time | -78.5% | +103.3% | -91.4% | +96.4% |
Chimerix Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $23.64 M(+51.0%) |
June 2024 | - | $15.66 M(-17.7%) |
Mar 2024 | - | $19.03 M(-31.2%) |
Dec 2023 | $27.66 M(+7.0%) | $27.66 M(+95.9%) |
Sept 2023 | - | $14.12 M(-29.8%) |
June 2023 | - | $20.10 M(+26.0%) |
Mar 2023 | - | $15.95 M(-38.3%) |
Dec 2022 | $25.84 M(+67.8%) | $25.84 M(-90.6%) |
Sept 2022 | - | $274.26 M(+876.5%) |
June 2022 | - | $28.09 M(-12.1%) |
Mar 2022 | - | $31.96 M(+107.6%) |
Dec 2021 | $15.40 M(-67.2%) | $15.40 M(-41.2%) |
Sept 2021 | - | $26.17 M(+2.9%) |
June 2021 | - | $25.45 M(-20.7%) |
Mar 2021 | - | $32.08 M(-31.7%) |
Dec 2020 | $46.99 M(+178.0%) | $46.99 M(+23.2%) |
Sept 2020 | - | $38.13 M(-28.7%) |
June 2020 | - | $53.50 M(+117.9%) |
Mar 2020 | - | $24.55 M(+45.3%) |
Dec 2019 | $16.90 M(-79.2%) | $16.90 M(-12.7%) |
Sept 2019 | - | $19.35 M(-10.6%) |
June 2019 | - | $21.64 M(+9.8%) |
Mar 2019 | - | $19.70 M(-75.7%) |
Dec 2018 | $81.11 M | $81.11 M(+252.8%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | $22.99 M(-16.2%) |
June 2018 | - | $27.45 M(+24.1%) |
Mar 2018 | - | $22.11 M(+19.2%) |
Dec 2017 | $18.55 M(-64.0%) | $18.55 M(+2.1%) |
Sept 2017 | - | $18.17 M(-23.9%) |
June 2017 | - | $23.89 M(+9.3%) |
Mar 2017 | - | $21.87 M(-57.5%) |
Dec 2016 | $51.46 M(+149.8%) | $51.46 M(+4.3%) |
Sept 2016 | - | $49.36 M(+54.0%) |
June 2016 | - | $32.06 M(+16.6%) |
Mar 2016 | - | $27.50 M(+33.5%) |
Dec 2015 | $20.61 M(-84.0%) | $20.61 M(-53.9%) |
Sept 2015 | - | $44.72 M(-65.0%) |
June 2015 | - | $127.78 M(+129.8%) |
Mar 2015 | - | $55.60 M(-56.7%) |
Dec 2014 | $128.46 M(+16.8%) | $128.46 M(+72.8%) |
Sept 2014 | - | $74.35 M(-37.8%) |
June 2014 | - | $119.60 M(+219.6%) |
Mar 2014 | - | $37.42 M(-66.0%) |
Dec 2013 | $109.98 M(+452.5%) | $109.98 M(-5.1%) |
Sept 2013 | - | $115.89 M(+0.4%) |
June 2013 | - | $115.44 M(+858.9%) |
Mar 2013 | - | $12.04 M(-39.5%) |
Dec 2012 | $19.91 M(+46.3%) | $19.91 M |
Dec 2011 | $13.61 M | - |
FAQ
- What is Chimerix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Chimerix?
- What is Chimerix annual cash & cash equivalents year-on-year change?
- What is Chimerix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Chimerix?
- What is Chimerix quarterly cash and cash equivalents year-on-year change?
What is Chimerix annual cash & cash equivalents?
The current annual cash & cash equivalents of CMRX is $27.66 M
What is the all time high annual cash & cash equivalents for Chimerix?
Chimerix all-time high annual cash & cash equivalents is $128.46 M
What is Chimerix annual cash & cash equivalents year-on-year change?
Over the past year, CMRX annual cash & cash equivalents has changed by +$1.82 M (+7.04%)
What is Chimerix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CMRX is $23.64 M
What is the all time high quarterly cash and cash equivalents for Chimerix?
Chimerix all-time high quarterly cash and cash equivalents is $274.26 M
What is Chimerix quarterly cash and cash equivalents year-on-year change?
Over the past year, CMRX quarterly cash and cash equivalents has changed by +$9.53 M (+67.48%)